Loading company…
Riskpilot
← Back to search
Sign in
Get full access
GENTIAN DIAGNOSTICS AB NUF
NUF
Active
Org 828157922
Bjørnåsveien 5, 1596 Moss
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 5,8M
-3% vs 2023
EBITDA margin
-13.0%
-333% vs 2023
Equity ratio
-86.0%
Financial strength
Net profit 2024
NOK -788K
-286% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
-1M
-100%
2024
Key figures
Annual report 2024
Revenue
NOK 5,8M
-3%
EBITDA
NOK -756K
-333%
Net profit
NOK -788K
-286%
Total assets
NOK 1,8M
-28%
Equity
NOK -1,5M
-107%
Employees
0
—
Company information
Legal name
GENTIAN DIAGNOSTICS AB NUF
Org number
828157922
Legal form
Norskregistrert Utenlandsk Foretak
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. juni 2023
Share capital
—
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Salg av analyser for medisinsk in vitro diagnostikk (ivd-produkter).
Contact
Address
Bjørnåsveien 5, 1596 Moss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Moss
All Norway companies
Revenue
NOK millions
0M
2M
3M
5M
7M
2M
2022
6M
2023
6M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
-1M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
1 926
6 032
5 828
Staff expenses
−0
−0
−0
EBITDA
−498
−175
−756
Depreciation & amort.
−0
−0
−0
EBIT
−498
−175
−756
Net financials
−32
−30
−32
Profit before tax
−530
−204
−788
Tax
−0
−0
−0
Net profit
−530
−204
−788
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
478
2 450
1 770
Equity
−530
−734
−1 522
Long-term debt
0
0
0
Short-term debt
1 008
3 183
3 292
Total debt
1 008
3 183
3 292
Financial ratios
5-year trend
EBITDA margin
-13.0%
This company
15.8%
Market median
-182% vs market
2022
2024
Equity ratio
-86.0%
This company
38.2%
Market median
-325% vs market
2022
2024
Return on equity
-78831000.0%
This company
18.4%
Market median
-428429448% vs market
2022
2024
Net profit margin
-13.5%
This company
8.1%
Market median
-267% vs market
2022
2024
Asset turnover
3.29×
This company
1.12×
Market median
+194% vs market
2022
2024
Debt / equity
2.16×
This company
0.62×
Market median
-248% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
NK
Njaal Kind
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of GENTIAN DIAGNOSTICS AB NUF also hold positions in
0
other companies.
Person
Role here
Other companies
Njaal Kind
Chief Executive Officer
0 companies